2-(1-苯甲酰基-5-甲氧基-2-甲基吲哚-3-基)乙酸 | 1601-19-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 2-(1-苯甲酰基-5-甲氧基-2-甲基吲哚-3-基)乙酸
• 英文名称: 1-benzoyl-5-methoxy-2-methylindole-3-acetic acid
• 英文别名: 2-(1-benzoyl-5-methoxy-2-methylindol-3-yl)acetic acid
• CAS: 1601-19-0
• 化学式: C₁₉H₁₇NO₄
• 分子量: 323.348
• InChiKey: HHVVFSZNIUHMEJ-UHFFFAOYSA-N

物化性质

• 熔点：
  172-173 °C
• 沸点：
  465.9±45.0 °C(Predicted)
• 密度：
  1.24±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  24
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.16
• 拓扑面积：
  68.5
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-(1-苯甲酰基-5-甲氧基-2-甲基吲哚-3-基)乙酸 在 三溴化硼 作用下， 以 二氯甲烷 为溶剂， 生成 2-(1-苯甲酰基-5-羟基-2-甲基吲哚-3-基)乙酸
  参考文献：
  名称：

  Synthesis of COX-2 and FAAH inhibitors

  摘要：

  描述了制备对COX-2抑制剂有用的吲哚和在这些方法中有用的中间体的方法。

  公开号：

  US20050234244A1
• 作为产物：
  描述：

  吲哚美辛 在 palladium on activated charcoal 氢气 、 三乙胺 作用下， 以 甲醇 为溶剂， 反应 25.0h， 以44%的产率得到2-(1-苯甲酰基-5-甲氧基-2-甲基吲哚-3-基)乙酸
  参考文献：
  名称：

  Mild and general procedure for Pd/C-catalyzed hydrodechlorination of aromatic chlorides

  摘要：

  A mild and efficient one-pot hydrodechlorination using a Pd/C-Et3N system proceeds at room temperature, which is general for the dechlorination of a variety of aromatic chlorides. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4039(02)01622-2

文献信息

• Deoxyfluorination of Carboxylic Acids with KF and Highly Electron-Deficient Fluoroarenes
  作者：Siyu Mao、Jordan H. Kramer、Haoran Sun

  DOI：10.1021/acs.joc.0c02491

  日期：2021.5.7

  A deoxyfluorination reaction of carboxylic acids using potassium fluoride (KF) and highly electron-deficient fluoroarenes is reported here, giving acyl fluorides in moderate to excellent yield (57–92% based on NMR integration and 34–95% for isolated examples).

  此处报道了使用氟化钾（KF）和高度缺电子的氟代芳烃进行的羧酸脱氧氟化反应，得到的酰基氟的收率中等至极佳（基于NMR积分，产率为57-92％，对于分离的实施例，产率为34-95％）。
• Esters and amides of substituted pyrrole acetic acids
  申请人：Cell Pathways, Inc.

  公开号：US05721347A1

  公开（公告）日：1998-02-24

  Esters and amides of substituted pyrrole acetic acids are useful in the treatment of colonic polyps.

  取代吡咯乙酸的酯和酰胺在治疗结肠息肉方面是有用的。
• SUBSTITUTED 2-(5-HYDROXY-2-METHYL-1H-INDOLE-3-YL)ACETIC ACIDS AND ETHERS THEREOF AND THE USE OF SAME TO TREAT VIRAL DISEASES
  申请人：Ivashchenko Andrey Alexandrovich

  公开号：US20110230524A1

  公开（公告）日：2011-09-22

  The present invention relates to novel substituted 2-(5-hydroxy-2-methyl-1H-indol-3-yl)acetic acids, to novel antiviral active ingredients, pharmaceutical compositions, antiviral medicaments, methods for prophylaxis and treatment of viral diseases particularly caused by influenza viruses and infectious hepatisis C (HCV) viruses. Novel substituted 2-(5-hydroxy-2-methyl-1H-indol-3-yl)acetic acids, their esters of the general formula 1 and pharmaceutically acceptable salts and/or hydrates thereof have been disclosed wherein: R 1 represents amino group substituent selected from hydrogen, optionally substituted C 1 -C 5 alkyl, acyl or sulfonyl; R 2 and R 4 independently of each other represent alkyl substituent selected from hydrogen, halogen, optionally substituted C 1 -C 3 alkyl, optionally substituted hydroxyl, optionally substituted amino group, optionally substituted aminomethyl, substituted mercapto group; R 3 represents hydrogen, optionally substituted lower C 1 -C 5 alkyl; R 5 represents cyclic system substituent selected from hydrogen, fluorine, trifluoromethyl, carboxy group, alkyloxycarbonyl, possibly substituted aryl, heterocyclyl, optionally substituted aminomethyl, cyano group; R 6 represents hydroxyl group substituent selected from hydrogen, optionally substituted C 1 -C 5 alkyl, acyl.

  本发明涉及新的取代2-(5-羟基-2-甲基-1H-吲哚-3-基)乙酸，新的抗病毒活性成分，制药组合物，抗病毒药物，以及用于预防和治疗由流感病毒和丙型肝炎病毒（HCV）引起的病毒性疾病的方法。已经披露了新的取代2-(5-羟基-2-甲基-1H-吲哚-3-基)乙酸，其酯具有一般式1和其药用可接受的盐和/或水合物其中：R1代表氨基取代基，可选地取代的C1-C5烷基，酰基或磺酰基；R2和R4独立地代表氢，卤素，可选地取代的C1-C3烷基，可选地取代的羟基，可选地取代的氨基基团，可选地取代的氨甲基，取代的巯基团；R3代表氢，可选地取代的较低C1-C5烷基；R5代表环系统取代基，选择自氢，氟，三氟甲基，羧基，烷氧羰基，可能取代的芳基，杂环烷基，可选地取代的氨甲基，氰基；R6代表羟基取代基，选择自氢，可选地取代的C1-C5烷基，酰基。
• CONJUGATES OF WATER SOLUBLE POLYMER-AMINO ACID OLIGOPEPTIDE-DRUG, PREPARATION METHOD AND USE THEREOF
  申请人：JENKEM TECHNOLOGY CO. LTD. TIANJIN BRANCH

  公开号：US20150359900A1

  公开（公告）日：2015-12-17

  A conjugate of water soluble polymer-amino acid oligopeptide-drug of Formula (I) below and a pharmaceutical composition comprising the conjugate are provided. In the conjugate, P is a water soluble polymer; X is a linking group, wherein the linking group links P and A 1 ; each of A 1 , A 2 and A 3 is independently same or different amino acid residue or amino acid analogue residue; each of D 1 and D 2 is independently same or different drug molecule residue; a is 0 or 1; b is an integer of 2-12; c is an integer of 0-7; d is 0 or 1. The conjugate could improve drug load capacity, water solubility, stability and activity of the drug.

  提供一种水溶性聚合物-氨基酸寡肽-药物的共轭物，其化学式（I）如下，并提供包含该共轭物的制药组合物。在该共轭物中，P是水溶性聚合物；X是一个连接基团，连接基团连接P和A1；A1、A2和A3中的每一个独立地是相同或不同的氨基酸残基或氨基酸类似物残基；D1和D2中的每一个独立地是相同或不同的药物分子残基；a为0或1；b是2-12的整数；c是0-7的整数；d为0或1。该共轭物能够提高药物的载荷能力、水溶性、稳定性和活性。
• Indole derivatives useful to treat estrogen-related neoplasms and
  申请人：——

  公开号：US05877202A1

  公开（公告）日：1999-03-02

  The present invention relates to novel indole derivatives useful in down-regulating estrogen receptor expression. Also included are methods for the treatment of neoplasms or of controlling the growth of a neoplasm in a patient afflicted with a neoplastic disease, especially estrogen-dependent neoplasms such as those associated with breast, ovarian and cervical tissue. Another embodiment of the present invention is a method of prophylactically treating a patient at risk of developing a neoplastic disease state. Also provided is a method for treating autoimmune diseases. Also included are pharmaceutical compositions of the novel indole derivatives.

  本发明涉及一种新型吲哚衍生物，可用于下调雌激素受体表达。还包括用于治疗肿瘤或控制患有肿瘤疾病的患者中的肿瘤生长的方法，特别是与乳腺、卵巢和宫颈组织相关的雌激素依赖性肿瘤。本发明的另一实施例是一种预防性治疗患有发展肿瘤疾病风险的患者的方法。还提供了一种用于治疗自身免疫疾病的方法。还包括新型吲哚衍生物的药物组合物。